The adjuvant CLDC increases protection of a herpes simplex type 2 glycoprotein D vaccine in guinea pigs-Reference-Cited by-同舟云学术

The adjuvant CLDC increases protection of a herpes simplex type 2 glycoprotein D vaccine in guinea pigs

Published:2010-05 Issue:21 Volume:28 Page:3748-3753
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Bernstein David I.,Farley Nicholas,Bravo Fernando J.,Earwood Julie,McNeal Monica,Fairman Jeff,Cardin Rhonda

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference25 articles.

1. Herpes simplex virus type 2: epidemiology and management options in developing countries;Paz-Bailey;Sex Transm Infect,2007

2. Genital herpes;Gupta;Lancet,2007

3. Potential for immunotherapy in the treatment of herpesvirus infections;Bernstein;Herpes,2001

4. Glycoprotein-D-adjuvant vaccine to prevent genital herpes;Stanberry;N Engl J Med,2002

5. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group;Corey;JAMA,1999

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging Trends in Lipid-Based Vaccine Delivery: A Special Focus on Developmental Strategies, Fabrication Methods, and Applications;Vaccines;2023-03-15

2. Immunisation Using Novel DNA Vaccine Encoding Virus Membrane Fusion Complex and Chemokine Genes Shows High Protection from HSV-2;Viruses;2022-10-22

3. Cross protective efficacy of the Non-Neurotropic live attenuated herpes simplex virus type 1 vaccine VC-2 is enhanced by intradermal vaccination and deletion of glycoprotein G;Vaccine;2022-10

4. Alphaherpesvirus Vaccines;Current Issues in Molecular Biology;2021

5. The R2 non-neuroinvasive HSV-1 vaccine affords protection from genital HSV-2 infections in a guinea pig model;npj Vaccines;2020-11-06